February 9, 2026

Intermittent fasting cuts Crohn’s disease activity by 40% and halves inflammation in randomized clinical trial

February 9, 2026 / Research update / InnovateMed Author / crohn diseases

by Crohn’s & Colitis Foundation of America edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain A randomized controlled study found that time-restricted feeding—a form of intermittent fasting—significantly reduced symptomatic disease activity and systematic inflammation in adults with Crohn’s disease and overweight or obesity. Results of […]

Intermittent fasting cuts Crohn’s disease activity by 40% and halves inflammation in randomized clinical trial Read More »

Cerebral-spinal fluid molecular test improves early and accurate diagnosis of multiple sclerosis

February 9, 2026 / Research update / InnovateMed Author / multiple sclerosis

by Chris Casey, CU Anschutz Medical Campus edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Annals of Neurology (2025). DOI: 10.1002/ana.78047 Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions, according to a new study that analyzed cryopreserved CSF samples from 160 individuals. The study

Cerebral-spinal fluid molecular test improves early and accurate diagnosis of multiple sclerosis Read More »

Speed-focused brain training tied to 25% lower dementia risk after 20 years

February 9, 2026 / Research update / InnovateMed Author / dementia risk

by Daniel Lawler edited by Andrew Zinin Editors’ notes The GIST Add as preferred source Dementia affects 57 million people and is the seventh leading cause of death globally. Researchers announced on Monday that a randomized controlled trial—considered the gold standard for medical research—has finally identified something capable of significantly lowering people’s risk of developing dementia.

Speed-focused brain training tied to 25% lower dementia risk after 20 years Read More »

The nervous system plays an active role in pancreatic cancer development, researchers discover

February 9, 2026 / Research update / InnovateMed Author / pancreatic cancer

by Cold Spring Harbor Laboratory edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Stress signals redesign tissues during inflammation and cancer. Left: Normal tissue maintenance. Right: Stress signals “switch on” fibroblasts, turning them into myCAFs (purple) that actively recruit nerves (cyan) into the pancreas. Credit: Tuveson lab/CSHL Notoriously tricky to

The nervous system plays an active role in pancreatic cancer development, researchers discover Read More »

Glyphosate: What Indigenous communities have suspected for years about the dangers of the herbicide

February 9, 2026 / Patient education / InnovateMed Author / glyphosphate

by Charles Z. Levkoe, The Conversation edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain There have been renewed questions around the safety of the herbicide glyphosate in light of the recent retraction of an influential peer-reviewed research article. Originally published in 2000 in the academic journal Regulatory Toxicology and

Glyphosate: What Indigenous communities have suspected for years about the dangers of the herbicide Read More »

Meal timing in time-restricted eating matters for metabolic health, find study

February 9, 2026 / Research update / InnovateMed Author / meal timing

by National Taiwan University edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Eating earlier in the day may better support metabolic health than eating late, even with similar eating durations. Credit: National Taiwan University, created using ChatGPT Time-restricted eating has emerged as a popular dietary approach because it focuses on

Meal timing in time-restricted eating matters for metabolic health, find study Read More »

The reason why many older Americans skip seasonal vaccines

February 9, 2026 / Clinical Practice / InnovateMed Author / vaccines

by Dennis Thompson edited by Andrew Zinin Editors’ notes The GIST Add as preferred source Many middle-aged folks and seniors are shrugging off their annual flu or COVID-19 shot for a very simple reason, a new survey has found. They just don’t think they need another jab. About 28% of people older than 50 didn’t get a flu shot

The reason why many older Americans skip seasonal vaccines Read More »

i-DNA ‘peek-a-boo structures’ form in living cells and regulate genes linked to cancer

February 9, 2026 / Clinical Practice / InnovateMed Author / genes

by Ingrid Söderbergh, Umea University edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Pallabi Sengupta, postdoctoral researcher at the Department of Medical Biochemistry and Biophysics at Umeå University, Sweden. Credit: Mattias Pettersson DNA’s iconic double helix does more than “just” store genetic information. Under certain conditions, it can temporarily fold

i-DNA ‘peek-a-boo structures’ form in living cells and regulate genes linked to cancer Read More »

Gambling impacts people’s quality of life as severely as chronic medical conditions, alcohol and illegal drugs

February 9, 2026 / Research update / InnovateMed Author / illegal drugs

by Alan Williams, University of Plymouth edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain The impacts of severe gambling pose similar threats to a person’s physical and mental well-being as a chronic health condition or alcohol and illegal drug use, a new study suggests. The research found that

Gambling impacts people’s quality of life as severely as chronic medical conditions, alcohol and illegal drugs Read More »

Chinese Medical Journal reports the safety and effectiveness of lecanemab in Chinese patients with early Alzheimer’s disease

February 9, 2026 / Research update / InnovateMed Author / alzheimer

Researchers report promising safety data and cognitive stabilization in Chinese patients with early alzheimer’s disease treated with lecanemab Peer-Reviewed PublicationChinese Medical Journals Publishing House Co., Ltd. image: Serial Aβ-PET scans are displayed at baseline (top row) to 6 months (middle row) and 12 months (bottom row) of treatment. For each time point, the right lateral

Chinese Medical Journal reports the safety and effectiveness of lecanemab in Chinese patients with early Alzheimer’s disease Read More »